Versameb has a novel proprietary technology platform for optimized and tailored, local delivery of therapeutic proteins. The optimised molecules have the potential to increase therapeutic potency and improve their residence at the targeted site. This increases therapeutic windows of potential candidates for both addressing unmet medical needs and improving existing therapies. Our platform can generate clinical candidates rapidly and can be applied in a broad variety of disease areas. Currently, we are prioritizing the field of tissue regeneration in both acute and chronic conditions.
To learn more about our technology platform, please click email@example.com.